Dr. Rodger Tiedemann
Dr. Rodger Tiedemann is a consultant haematologist who has highlighted the challenges faced by myeloma patients in New Zealand, where access to the drug daratumumab is limited. He advocates for improved funding and better treatment options for blood cancer patients, emphasizing the critical need for effective therapies to enhance survival rates and quality of life.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| New Zealand | 1 | 6.00 | 0.08% | +0% | 4,822,233 | 3,631 | $210,000 | 158$ |
| Totals | 1 | 4,822,233 | 3,631 | $210,000 | 158$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Consultant haematologist Dr. Rodger Tiedemann told sand about 400 people are diagnosed with myeloma every year, and many patients would benefit from dara.
6